This page contains testimony given by FLCCC physicians to federal, state, and local government agencies as well as organizations of doctors and hospitals concerning treatment of patients who are severely ill with COVID-19 and the effectiveness of the MATH+ treatment protocol.
Dr. Pierre Kory (FLCCC Alliance) testifies to senate committee about I-MASK+ (incl. Q & A) (Dec 8, 2020)
The ‘NewsNOW’ feed of Dr. Kory’s impressive testimony had 5 million views on YouTube within the first 10 days (after 6 weeks deleted by Youtube, like our own YT version before)
Appearing as a witness Tuesday morning, Dec 8, 2020, before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on ivermectin. The data shows the ability of the drug ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.
Dr. Kory testified that ivermectin is effectively a “miracle drug” against COVID-19 and called upon the government’s medical authorities — the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe ivermectin for COVID-19. You will find all relevant information on the FLCCC Alliance’s prophylaxis and treatment protocols for COVID-19 on this website.
Dr. Kory testifies before U.S. Senate Committee on Homeland Security and Governmental Affairs on treating COVID-19 (May 6, 2020)
A fruitless attempt to convince the committee of the life-saving efficacy of our MATH+ Hospital Treatment Protocol for COVID-19, against the recommendations against the use of corticosteroids in COVID-19 made by WHO and NIH at that time. The efficacy of corticosteroids to combat the cytokine storm resulting from an immune system overreaction to the SARS-CoV-2 virus, the most common cause of death in COVID-19, was then confirmed in the so-called RECOVERY study in Oxford (June 2020).